B cell–derived acetylcholine mitigates skin inflammation in mice through α9 nicotinic acetylcholine receptor–mediated signaling
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2501960122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Erica Foffi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G2M9, Canada. Hauptthemen laut MEDLINE: Acetylcholine, Receptors, Nicotinic, B-Lymphocytes, Signal Transduction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR).
Abstract (Originalsprache)
Chronic inflammatory skin disorders are characterized by keratinocyte hyperproliferation and hyperactivation as well as immune cell infiltration. We investigated whether immune cell–derived acetylcholine (ACh) is a modulator of skin inflammation in mice. Here, we identify skin epithelial B cells as a key source of ACh that damps down inflammation. We used imiquimod (IMQ) to induce inflammatory skin disease (ISD) in mice lacking ACh production specifically in B cells (ChAT fl/fl;Mb1-Cre mice). Increased keratinocyte proliferation, epidermal thickening, and elevated levels of proinflammatory cytokines resulted. ACh binding to α9 nicotinic ACh receptor (encoded by Chrna9 ) expressed on wild-type mouse keratinocytes reduced their proliferation. Chrna9 -deficient mice exhibited the same exacerbated ISD phenotype as ChAT fl/fl;Mb1-Cre mice following IMQ induction. Our data suggest that B cell–derived ACh maintains skin homeostasis by modulating keratinocyte turnover and controlling immune-related inflammation. Therapeutic manipulation of this cholinergic pathway might mitigate both keratinocyte dysfunction and immune dysregulation in human patients, potentially pointing to treatments for ISDs such as psoriasis and related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G2M9, Canada.
- Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G2M9, Canada.
- Istituto Dermopatico dell'Immacolata - Istituto di Ricovero e Cura a Carattere Scientifico, Rome 00167, Italy.
- Department of Experimental Medicine, Torvergata Onscoscience Research, University of Rome Tor Vergata, Rome 00133, Italy.
- Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong Special Administrative Region, China.
- Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong Special Administrative Region, China.
ORCID-Profile: Eleonora Candi, Gerry Melino, Tak W Mak
Förderung
- Canadian Government | Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Foffi, E., Rugolo, F., Ramamurthy, N., Haight, J., Helke, S., You-Ten, A., Tobin, C., Jafari, S. M., Elia, A. J., Berger, T., Candi, E., Melino, G., & Mak, T. W. (2025). B cell–derived acetylcholine mitigates skin inflammation in mice through α9 nicotinic acetylcholine receptor–mediated signaling. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2501960122
Vancouver
Foffi E, Rugolo F, Ramamurthy N, Haight J, Helke S, You-Ten A, et al. B cell–derived acetylcholine mitigates skin inflammation in mice through α9 nicotinic acetylcholine receptor–mediated signaling. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2501960122
BibTeX
@article{Foffi2025,
author = {Foffi, Erica and Rugolo, Francesco and Ramamurthy, Nisha and Haight, Jillian and Helke, Simone and You-Ten, Annick and Tobin, Chantal and Jafari, Soode Moghadas and Elia, Andrew J and Berger, Thorsten and Candi, Eleonora and Melino, Gerry and Mak, Tak W},
title = {B cell–derived acetylcholine mitigates skin inflammation in mice through α9 nicotinic acetylcholine receptor–mediated signaling},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2501960122}
}
EUVIMED